Earnings
Key Metrics
Income Statement
Balance Sheet
Cash Flow
Shareholder Return
Reporting period: 2025.01.01-2025.12.31
Summary: ILUVATAR COREX (09903) reported Revenue of 1.03B(+91.58%); Operating profit of -983.06M(-12.34%); Net profit attributable to owners of -1.00B(-12.46%).
Reported YoY
Prior Year YoY
Net profit attributable to owners Down YoY
Net profit attributable to owners
Reporting period: 2026.01.01-2026.06.30
Summary: ILUVATAR COREX (09903) reported Revenue of 945.68M(+191.64%); Net profit attributable to owners of 106.27M(+117.44%).
Reported YoY
Prior Year YoY
Net profit attributable to owners Up YoY
-609.32M --
Net profit attributable to owners
Unit: CNY
FY 2022
FY 2023
FY 2024
FY 2025
Gross margin
59.36% -- 49.53% 9.84%49.13% 0.39%53.99% 4.85%
Net margin
-292.35% -- -282.81% 9.54%-165.42% 117.39%-97.10% 68.31%
ROE
-79.25% -- -85.76% 6.50%-129.59% 43.83%-42.65% 86.94%
ROA
-52.89% -- -51.31% 1.58%-52.96% 1.64%-25.66% 27.30%
Revenue growth
-- -- 52.63% -- 86.66% 34.02%91.58% 4.93%
Attributable profit growth
-- -- -51.06% -- -12.78% 38.28%-12.46% 0.32%
Debt-to-assets
40.80% -- 44.86% 4.07%59.13% 14.27%39.85% 19.28%
Current ratio
2.48 -- 1.88 0.601.43 0.443.09 1.65
Operating cash flow / net profit
1.18 -- 0.86 0.320.69 0.171.16 0.46
Operating cash flow / revenue
-345.28% -- -244.61% 100.67%-114.54% 130.07%-112.38% 2.16%
Gross margin
50.09% -- 17.19% 32.90%
Net margin
-187.91% -- 11.24% 199.15%
Revenue growth
-- -- 191.64% --
Attributable profit growth
-- -- 117.44% --
Debt-to-assets
-- -- 40.82% --
Current ratio
-- -- 3.71 --
Operating cash flow / net profit
1.17 -- -26.21 27.39
Operating cash flow / revenue
-220.68% -- -294.56% 73.87%
Unit: CNY
FY 2022
FY 2023
FY 2024
FY 2025
Revenue
189.37M -- 289.04M 52.63%539.51M 86.66%1.03B 91.58%
Other income and gains
33.77M -- 20.11M 40.46%44.98M 123.75%97.03M 115.69%
Gross profit
112.41M -- 143.15M 27.34%265.08M 85.18%557.99M 110.50%
Selling and distribution expenses
48.72M -- 88.26M 81.17%122.36M 38.64%151.55M 23.86%
Administrative expenses
166.04M -- 242.02M 45.76%257.29M 6.31%481.82M 87.27%
Net finance costs
6.50M -- 11.01M 69.26%17.38M 57.93%20.60M 18.49%
Operating profit
-547.12M -- -806.42M 47.39%-875.05M 8.51%-983.06M 12.34%
Profit before tax
-553.62M -- -817.42M 47.65%-892.43M 9.18%-1.00B 12.46%
Net profit
-553.62M -- -817.42M 47.65%-892.43M 9.18%-1.00B 12.46%
Net profit attributable to owners
-523.84M -- -791.31M 51.06%-892.43M 12.78%-1.00B 12.46%
Revenue
324.26M -- 945.68M 191.64%
Other income and gains
39.54M -- 873.32M 2108.76%
Cost of sales
161.83M -- 783.12M 383.91%
Gross profit
162.43M -- 162.56M 0.08%
Selling and distribution expenses
67.61M -- 82.44M 21.94%
Administrative expenses
274.59M -- 158.14M 42.41%
Net finance costs
11.14M -- 20.31M 82.34%
Income tax
0 -- 0 --
Profit before tax
-609.32M -- 106.27M 117.44%
Net profit
-609.32M -- 106.27M 117.44%
Net profit attributable to owners
-609.32M -- 106.27M 117.44%
Cash and cash equivalents YoY
Unit: CNY
FY 2022
FY 2023
FY 2024
FY 2025
Cash and cash equivalents
219.31M -- 308.05M 40.47%313.56M 1.79%1.50B 379.87%
Trade and bills receivables
88.71M -- 222.80M 151.16%403.23M 80.98%587.46M 45.69%
Inventories
244.02M -- 232.60M 4.68%342.64M 47.31%709.76M 107.14%
Total current assets
785.09M -- 1.29B 63.95%1.26B 1.93%3.43B 171.88%
Total assets
1.05B -- 1.59B 52.19%1.69B 5.79%3.91B 132.14%
Total current liabilities
316.71M -- 686.47M 116.75%879.96M 28.19%1.11B 26.42%
Total liabilities
427.00M -- 714.64M 67.36%996.51M 39.44%1.56B 56.44%
Equity attributable to owners
660.98M -- 922.74M 39.60%688.67M 25.37%2.35B 241.69%
Total equity
619.68M -- 878.34M 41.74%688.67M 21.59%2.35B 241.69%
Cash and cash equivalents YoY
Cash and cash equivalents
-- -- 2.91B --
Trade and bills receivables
-- -- 1.24B --
Inventories
-- -- 1.97B --
Total current assets
-- -- 9.10B --
Total assets
-- -- 9.80B --
Total current liabilities
-- -- 2.45B --
Total liabilities
-- -- 4.00B --
Equity attributable to owners
-- -- 5.80B --
Total equity
-- -- 5.80B --
Net cash from operating activities YoY
Unit: CNY
FY 2022
FY 2023
FY 2024
FY 2025
Net cash from operating activities
-653.85M -- -707.03M 8.13%-617.98M 12.59%-1.16B 87.96%
Net cash from investing activities
-183.08M -- -153.49M 16.16%-165.98M 8.14%-132.25M 20.32%
Net cash from financing activities
953.16M -- 946.48M 0.70%789.47M 16.59%2.49B 215.51%
Net change in cash
116.24M -- 85.97M 26.04%5.51M 93.59%1.20B 21625.08%
Net cash from operating activities YoY
Net cash from operating activities
-715.59M -- -2.79B 289.27%
Net cash from investing activities
-51.19M -- -650.83M 1171.38%
Net cash from financing activities
2.17B -- 4.86B 124.07%
Net change in cash
1.40B -- 1.42B 1.45%
Dividend Details
Dividend Details
Ex-date
Payment Date
Record Date
Special
每1股派送2股
2026-09-15
2026-09-22
2026/09/17-2026/09/18
1 : 2
Capitalisation Issue
上海天數智芯半導體建議按每1股股份發行2股資本化股份(每1股送2股紅股)的方式將資本儲備資本化,並提請臨時股東會審議。
1 : 2
Capitalisation Issue
建議按每持有1股獲發2股新股份的基準進行資本化發行(紅股),以269,174,736股為基準合共發行538,349,472股新股份,發行後總股本增至807,524,208股,並建議相應增加註冊資本及修改公司章程。
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows ILUVATAR COREX (09903) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.
Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect